Mono Pharmacare Ltd

Mono Pharmacare Annual General Meeting

Mono Pharmacare Limited has fixed September 23, 2026, as the record date for remote e-voting eligibility for its Annual General Meeting.

Mono Pharmacare Legal & Regulatory

Mono Pharmacare received NSE fines totaling Rs. 0.02 Crore for non-compliance with SEBI Regulations 33 and 76. The Board has advised strengthening the company's compliance mechanism.

Value

₹0.02 Cr

Mono Pharmacare Annual General Meeting

Mono Pharmacare Limited has issued a notice for its 4th Annual General Meeting scheduled for September 30, 2026, at its registered office in Ahmedabad.

Mono Pharmacare Board Meeting Outcome

Mono Pharmacare Limited's board meeting approved the re-appointment of a director, the appointment of new statutory auditors, and the scheduling of the company's 4th AGM.

Mono Pharmacare Board Meeting Date

Mono Pharmacare Limited has scheduled a board meeting for September 3, 2026, to discuss other business matters.

Mono Pharmacare Other Announcement

Mono Pharmacare Limited has appointed M/s. B G Kalal & CO as Internal Auditor for FY 2026-27. The board approved this based on Audit Committee recommendations.

Execution

Financial Year 2026-27

Mono Pharmacare Management Change

Mr. Rahul Joshi resigned as Company Secretary and Compliance Officer effective July 1, 2026. The resignation cited pending salary dues and non-payment of salary.

Mono Pharmacare Board Meeting Outcome

Mono Pharmacare approved FY2026 audited financial results and appointed new internal and secretarial auditors. The company also noted the resignation of Company Secretary Rahul Joshi.

Mono Pharmacare Board Meeting Date

Mono Pharmacare scheduled a board meeting on July 09, 2026. The board will consider audited annual financial results for March 2026.

Mono Pharmacare Legal & Regulatory

Mono Pharmacare paid a ₹9,676 fine for SEBI Regulation 31 non-compliance. The Board noted the lapse and directed stronger compliance controls.

Value

₹0.01 Cr

Mono Pharmacare Annual General Meeting

Mono Pharmacare held an EGM on June 30, 2026. The meeting approved the appointment of a Statutory Auditor and Independent Director.

Mono Pharmacare Annual General Meeting

Mono Pharmacare Limited has convened an EGM on June 30, 2026. Shareholders will vote on appointing M/s. R K Mergu & Co. as auditors and regularizing Ms. Nirmala Ranawat's appointment.

Mono Pharmacare Board Meeting Outcome

Mono Pharmacare's board approved the appointment of Nirmala Ranawat as Independent Director and reconstituted various committees. The board also decided to convene an Extraordinary General Meeting.

Mono Pharmacare Other Announcement

Mono Pharmacare Limited filed a non-applicability confirmation for quarterly corporate governance reports. As an SME-listed entity, it remains exempt from Regulation 27(2) compliance requirements.

Mono Pharmacare Management Change

Mono Pharmacare Limited has received consent from Ms. Nirmala Ranawat for her appointment as an Independent Director. Her professional background includes extensive corporate law and taxation experience.

Mono Pharmacare Board Meeting Date

Mono Pharmacare Limited has scheduled a Board Meeting for June 03, 2026. The meeting will primarily address other business matters as per the agenda.

Mono Pharmacare Management Change

Mono Pharmacare Limited announced the resignation of its Internal Auditor, M/s. Kaliya & Associates, effective May 4, 2026. The change was disclosed as a routine regulatory filing regarding Key Managerial Personnel/Auditors and does not involve any stated financial impact.

Mono Pharmacare Management Change

M/s. Kaliya & Associates has resigned as the Internal Auditor of Mono Pharmacare Limited effective May 5, 2026. The resignation is attributed to inordinate delays in the finalization of accounts for FY 2025-26, which prevented the auditors from performing their duties in accordance with professional standards and independence requirements.

Mono Pharmacare Annual General Meeting

Mono Pharmacare Limited has deferred its Extra-Ordinary General Meeting (EGM) originally scheduled for April 30, 2026, due to unavoidable circumstances. The company will announce a revised schedule in due course in compliance with applicable laws.